# Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

> **NCT06004167** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 10 (actual)

## Conditions studied

- Lymphoma, B-Cell
- Relapsed Cancer
- Refractory Lymphoma
- Diffuse Large B Cell Lymphoma
- Mediastinal Large B-cell Lymphoma
- High-grade B-cell Lymphoma
- Follicular Lymphoma
- Mantle Cell Lymphoma

## Interventions

- **RADIATION:** Adaptive Bridging Radiation Therapy (ABRT)

## Key facts

- **NCT ID:** NCT06004167
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-14
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06004167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06004167, "Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06004167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*